{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:35:38Z","timestamp":1773182138625,"version":"3.50.1"},"update-to":[{"DOI":"10.1016\/j.bone.2013.03.018","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"record-id":"18799"},{"DOI":"10.1016\/j.bone.2013.03.018","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000}}],"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.bone.2013.03.018","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T20:14:21Z","timestamp":1365192861000},"page":"113-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["RETRACTED: Atypical incomplete femoral fractures in asymptomatic patients on long term bisphosphonate therapy"],"prefix":"10.1016","volume":"55","author":[{"given":"M.B.","family":"Allison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Markman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.L.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Babb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Tejwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Peck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2013.03.018_bb0005","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2013.03.018_bb0010","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonate: mechanisms of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bone.2013.03.018_bb0015","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years' experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2013.03.018_bb0020","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1359\/jbmr.081247","article-title":"Subtronchanteric and diaphyseal femur fractures in patient treated with alendronate: a register-based national cohort study","volume":"24","author":"Abrahamsen","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.03.018_bb0025","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/ageing\/afp106","article-title":"Spontaneous femoral shaft fracture after long-term alendronate","volume":"38","author":"Ali","year":"2009","journal-title":"Age Ageing"},{"key":"10.1016\/j.bone.2013.03.018_bb0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00223-009-9263-5","article-title":"Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates: a case series","volume":"85","author":"Armamento-Villareal","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2013.03.018_bb0035","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.2106\/JBJS.H.01774","article-title":"Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy","volume":"91","author":"Capeci","year":"2009","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.bone.2013.03.018_bb0040","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s11999-009-1192-0","article-title":"Case reports: subtrochanteric femoral stress fractures after prolonged alendronate therapy","volume":"468","author":"Cermak","year":"2010","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.bone.2013.03.018_bb0045","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00198-009-0986-y","article-title":"Alendronate-related femoral diaphysis fracture \u2014 what should be done to predict and prevent subsequent fracture of the contralateral side?","volume":"21","author":"Edwards","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2013.03.018_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3928\/01477447-20090624-27","article-title":"Atraumatic bilateral femur fracture in long-term bisphosphonate use","volume":"32","author":"Goddard","year":"2009","journal-title":"Orthopedics"},{"key":"10.1016\/j.bone.2013.03.018_bb0055","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1302\/0301-620X.89B3.18146","article-title":"Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution","volume":"89","author":"Goh","year":"2007","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.bone.2013.03.018_bb0060","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2165\/00002018-200932090-00002","article-title":"Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital","volume":"32","author":"Ing-Lorenzini","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.bone.2013.03.018_bb0065","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.injury.2007.08.036","article-title":"An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?","volume":"39","author":"Kwek","year":"2008","journal-title":"Injury"},{"key":"10.1016\/j.bone.2013.03.018_bb0070","first-page":"317","article-title":"More on atypical fractures of the femoral diaphysis","volume":"359","author":"Lee","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2013.03.018_bb0075","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMc0707493","article-title":"Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate","volume":"358","author":"Lenart","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2013.03.018_bb0080","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00198-008-0805-x","article-title":"Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study","volume":"20","author":"Lenart","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2013.03.018_bb0085","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","article-title":"Low-energy femoral shaft fractures associated with alendronate use","volume":"22","author":"Neviaser","year":"2008","journal-title":"J Orthop Trauma"},{"key":"10.1016\/j.bone.2013.03.018_bb0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2265.2009.03581.x","article-title":"Unusual mid-shaft fractures during long term bisphosphonate therapy","volume":"72","author":"Odvina","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.bone.2013.03.018_bb0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/17453670710015580","article-title":"Subtrochanteric displaced insufficiency fracture after long-term alendronate therapy \u2014 a case report","volume":"79","author":"Sayed-Noor","year":"2008","journal-title":"Acta Orthop"},{"key":"10.1016\/j.bone.2013.03.018_bb0100","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s11999-009-0725-x","article-title":"Case reports: two femoral insufficiency fractures after long-term alendronate therapy","volume":"467","author":"Sayed-Noor","year":"2009","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.bone.2013.03.018_bb0105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/17453670903139914","article-title":"Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate","volume":"80","author":"Schilcher","year":"2009","journal-title":"Acta Orthop"},{"key":"10.1016\/j.bone.2013.03.018_bb0110","first-page":"18","article-title":"Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk","volume":"64","author":"Schneider","year":"2009","journal-title":"Geriatrics"},{"key":"10.1016\/j.bone.2013.03.018_bb0125","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research","volume":"25","author":"Shane","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.03.018_bb0130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF03345598","article-title":"Effect of inappropriate and continuous therapy with alendronate for ten years on skeletal integrity \u2014 observations in two elderly patients","volume":"31","author":"Tucci","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.bone.2013.03.018_bb0135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF03026321","article-title":"The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib","volume":"23","author":"Mashiba","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.bone.2013.03.018_bb0170","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bone.2010.05.019","article-title":"Atypical fractures of the femur and bisphosphonate therapy: a systematic review of case\/case series studies","volume":"2","author":"Giusti","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.03.018_bb0180","series-title":"ASBMR 2010 Annual Meeting, Toronto, Canada","article-title":"A retrospective analysis of all atypical femoral fractures seen in a large California HMO from the years 2007 to 2009","author":"Dell","year":"2010"},{"key":"10.1016\/j.bone.2013.03.018_bb0195","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2214\/AJR.10.6262","article-title":"Bisphosphonate-related complete atypical subtrochanteric femoral fractures: diagnostic utility of radiography","volume":"197","author":"Rosenberg","year":"2011","journal-title":"AJR"},{"issue":"5","key":"10.1016\/j.bone.2013.03.018_bb0200","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/jbmr.1550","article-title":"Incidence and demography of femur fractures with and without atypical features","volume":"27","author":"Feldstein","year":"2012","journal-title":"JBMR"}],"updated-by":[{"DOI":"10.1016\/j.bone.2013.03.018","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"record-id":"18799"},{"DOI":"10.1016\/j.bone.2013.03.018","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000}}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821300135X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821300135X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T21:40:06Z","timestamp":1556746806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632821300135X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S875632821300135X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2013.03.018","relation":{"retraction":[{"id-type":"doi","id":"10.1016\/j.bone.2013.03.018","asserted-by":"object"}]},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Atypical incomplete femoral fractures in asymptomatic patients on long term bisphosphonate therapy","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2013.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}